Cassandra Barksdale of Atlanta alleges a lab mix-up at Kaiser Permanente produced a false diagnosis of aggressive uterine cancer that led to a May 15 hysterectomy. Post-surgery pathology reportedly showed no malignancy, and months later DNA testing allegedly confirmed the cancerous specimen belonged to another patient. The suit says the error deprived her of reproductive choice and caused lasting emotional harm; Kaiser says it has taken steps to prevent recurrence and is working to resolve the matter.
Atlanta Woman Says Lab Mix-Up at Kaiser Led to False Cancer Diagnosis and Unnecessary Hysterectomy
Cassandra BarksdaleCredit: Courtesy of The Edmond Firm
An Atlanta mother of two is suing Kaiser Permanente after an alleged laboratory error led to a false diagnosis of aggressive uterine cancer and an unnecessary hysterectomy, the complaint says.
What Happened
Cassandra Barksdale first sought care for bleeding and uterine fibroids in January 2025. According to the filing, on or about March 17 she was told by phone that she had a high-grade, aggressive endometrial (uterine) cancer and that surgery was the only viable treatment option.
On May 15, 2025, Barksdale underwent surgery in which her uterus, cervix, ovaries, fallopian tubes and four lymph nodes were removed. The next day, however, a report on the surgically removed tissue reportedly found that "no morphologically malignant cells are seen." Within a week, the surgical pathology report allegedly confirmed that no carcinoma was identified in the submitted endometrial tissue.
Conflicting Information and DNA Findings
The complaint alleges ongoing confusion and mixed messages from the health system: on June 1 she was reportedly told she had no evidence of cancer, but at a July 1 appointment she was again told she had cancer and needed chemotherapy. For months, she says, she received little substantive information about her care.
Cassandra Barksdale with her two sonsCredit: Courtesy of The Edmond Firm
On September 23, 2025, Kaiser Permanente administrators reportedly informed Barksdale that DNA testing showed the specimen originally reported as an aggressive, high-grade endometrial cancer did not belong to her. A copy of the test results reviewed by news outlets reportedly included this addendum:
THIS SPECIMEN BELONGS TO A DIFFERENT PATIENT. THE TEST HAS BEEN CANCELED.
Allegations and Impact
The lawsuit argues that a laboratory mix-up and subsequent miscommunication deprived Barksdale of the ability to make informed decisions about her body. Her attorney, Shannan Young, told reporters the case is as much about bodily autonomy as malpractice: Barksdale was forced into surgical menopause, continues to suffer emotional trauma, and lost the ability to have another biological child as a result of the alleged error.
Kaiser Permanente's Response
A Kaiser Permanente representative provided a statement acknowledging the incident and the profound effects such a mistake can have. The statement said the organization has "highly trained staff and very thorough processes" to prevent errors, that immediate steps were taken after the event to prevent recurrence, and that Kaiser is "committed to working with Ms. Barksdale and her counsel to resolve this in the most fair and accountable way we can."
What Comes Next
The lawsuit seeks accountability and damages for the physical and emotional harm alleged. The case highlights risks tied to laboratory specimen handling, the need for clear patient communication, and broader questions about patient consent and reproductive rights when medical errors occur.
Help us improve.
